OVERVIEW

2nd Annual eyeforpharma Medical Affairs USA is organized by eyeforpharma and will be held during Apr 10 - 11, 2018 at Pennsylvania Convention Center, Philadelphia, Pennsylvania, United States of America.

The need for Medical Affairs has never been greater. HCPs demand more open, science-based dialog; payers require increased value demonstration and real-world studies; and patient voices have never been heard louder.

The ability of medical to provide answers has heightened expectations and transformed the department’s influence, importance and responsibility.

From ensuring the patient voice is heard throughout the core of your company, to mastering the explosion of real-world data, revolutionizing the medical model and leading the charge to value-driven healthcare – this summit will focus on the key issues relevant to you.

Key speakers include :
• Rob Scott, CMO, VP Global Development, Abbvie
• Sotirios Stergiopoulos, CMO, Senior Vice President and Head of Global Medical Affairs, Ipsen
• Chris Keenan, Head, Worldwide Medical Customer Engagement, Medical Capabilities, BMS
• Vivian Herrera, Executive Director, Head of HEOR Payer Strategy, Novartis
• Pol Vandenbroucke, Vice President, Medical Strategy, Pfizer

Prices :
Gold Pass: USD 2499
Silver Pass: USD 2199

Speakers :
* Rob Scott,
* Sotirios Stergiopoulos,
* Pablo Lapuerta,
* Sandy Leonard,
* Pol Vandenbroucke,
* Scott Williams,
* Vivian Herrera,
* Chris Keenan,
* Juan Ochoa,
* Eddie Power,
* Suzanne Belinson,
* John Graham,
* Raymond Hill,
* Jefferson Tea,
* Gary Kaplan,
* Luca Dezzani,
* Eric Wittbrodt,
* Kathy Foris,
* Gema Parlange,
* Leanne Larson

Additional details will be posted as soon as they are available.

KEY DATES

Event Start Date
10 Apr, 2018
Event Start Date
Event End Date
11 Apr, 2018
Event End Date

SPECIALITIES

Pharmacy and Medicine

SUGGESTED HOTELS

CONFERENCE VENUE

LocationPennsylvania Convention Center
1101 Arch St

RELATED CONFERENCES & LIVE WEBINARS

Jul 23 - 24, 2026 | Vienna, Wien, AT

Research and Clinical Research
More actions
AT€350